Contribution: Industrial Research Assistance Program – Contributions to Firms
Orion Biotechnology Canada Ltd.
$252,953.00
In vitro and in vivo Studies of OB-002
FY 2021-22 · 2021-05-03
Summary
In vitro and in vivo studies will be conducted to further characterize
OB-002.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Ottawa|Ottawa, Ontario, Canada
Recipient Type
For-profit organization
Business Number
708721493
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2021-05-03 | 2021-22 | $211,145.00 |
| 1 | 2021-05-03 | 2021-22 | $211,145.00 |
| 2 | 2021-05-03 | 2021-22 | $252,953.00 |
| 3 | 2021-05-03 | 2021-22 | $252,953.00 |
| 4 | 2021-05-03 | 2021-22 | $252,953.00 |
| 5 | 2021-05-03 | 2021-22 | $252,953.00 |
| 6 | 2021-05-03 | 2021-22 | $252,953.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 92 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 92 jours.
Agreement End Date
2024-05-31
Agreement Number
978814
Agreement Start Date
2021-05-03
Agreement Title
In vitro and in vivo Studies of OB-002
Agreement Title (French)
Études in vitro et in vivo de l'OB-002
Agreement Type
Contribution
Agreement Value
$252,953.00
Amendment Date
2024-03-12
Amendment Number
6
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
In vitro and in vivo studies will be conducted to further characterize
OB-002.
Description (French)
Des études in vitro et in vivo seront menées pour caractériser davantage l'OB-002.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Ottawa Centre
Federal Riding (French)
Ottawa-Centre
Federal Riding Number
35075
NAICS Code
325410
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
708721493
Recipient City
Ottawa|Ottawa
Recipient Country
CA
Recipient Legal Name
Orion Biotechnology Canada Ltd.
Recipient Postal Code
K1S 1N4
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2021-2022-Q3-978814
